Search for: "Myers v. Long et al" Results 41 - 60 of 63
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Sep 2015, 7:43 am by Associates and Bruce L. Scheiner
Cameo Theatre et al., security video showed the bouncer confronting the student at one of the nightclub’s side doors. [read post]
17 Jan 2021, 6:15 pm by Omar Ha-Redeye
Corcoran and Pritchard v Van Nes. [read post]
30 Nov 2011, 3:00 pm by Steve Davies
’” ABA Section of Environment, Energy, and Resources, “Endangered Species Act,” 172 (Donald Baur et al., eds., 2nd ed. 2010) (citing National Wildlife Federation v. [read post]
7 Dec 2011, 11:15 am by lawmrh
The Presiding Justices of The First, Second, Third and Fourth Departments et. al. [read post]
26 Mar 2011, 5:00 pm
Bristol-Myers Squibb Co. v. [read post]
4 Jun 2017, 9:09 pm by Hannah Dockendorff
Webster et. al., Changes in Tropical Cyclone Number, Duration, and Intensity in a Warming Environment 309 Science 1844 (2005)). [read post]
4 Jun 2017, 9:09 pm by Hannah Dockendorff
Webster et. al., Changes in Tropical Cyclone Number, Duration, and Intensity in a Warming Environment 309 Science 1844 (2005)). [read post]
4 Jun 2017, 9:09 pm by Hannah Dockendorff
Webster et. al., Changes in Tropical Cyclone Number, Duration, and Intensity in a Warming Environment 309 Science 1844 (2005)). [read post]
22 Mar 2024, 4:00 am by Guest Blogger
Afflicted with a “culture of complacency[1],” the Ontario Superior Court has long struggled to timely advance cases to trial. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
12 Jan 2017, 7:01 am by John Elwood
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]